149 related articles for article (PubMed ID: 10685528)
1. Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation.
Fanchin R; de Ziegler D; Taieb J; Olivennes F; Castracane VD; Frydman R
Fertil Steril; 2000 Feb; 73(2):275-9. PubMed ID: 10685528
[TBL] [Abstract][Full Text] [Related]
2. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
[TBL] [Abstract][Full Text] [Related]
3. Physiopathology of premature progesterone elevation.
Fanchin R; de Ziegler D; Castracane VD; Taieb J; Olivennes F; Frydman R
Fertil Steril; 1995 Oct; 64(4):796-801. PubMed ID: 7672153
[TBL] [Abstract][Full Text] [Related]
4. Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation.
Frydman R; Cornel C; de Ziegler D; Taieb J; Spitz IM; Bouchard P
Fertil Steril; 1991 Nov; 56(5):923-7. PubMed ID: 1936328
[TBL] [Abstract][Full Text] [Related]
5. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
6. Premature plasma progesterone and androgen elevation are not prevented by adrenal suppression in in vitro fertilization.
Fanchin R; Righini C; Olivennes F; Taieb J; de Ziegler D; Frydman R
Fertil Steril; 1997 Jan; 67(1):115-9. PubMed ID: 8986694
[TBL] [Abstract][Full Text] [Related]
7. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy.
Fanchin R; Righini C; Olivennes F; Ferreira AL; de Ziegler D; Frydman R
Fertil Steril; 1997 Nov; 68(5):799-805. PubMed ID: 9389805
[TBL] [Abstract][Full Text] [Related]
8. Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.
Gelety TJ; Surrey ES
J Assist Reprod Genet; 1997 Oct; 14(9):525-30. PubMed ID: 9401871
[TBL] [Abstract][Full Text] [Related]
9. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
11. Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation.
Fanchin R; Righini C; Olivennes F; Taieb J; de Ziegler D; Frydman R
Fertil Steril; 1999 Jan; 71(1):174-81. PubMed ID: 9935138
[TBL] [Abstract][Full Text] [Related]
12. The comparison of microdose flare-up and multiple dose antagonist protocols based on hCG day estradiol (E2), progesterone (P) and P/E2 ratio among poor responder patients in ICSI-ET cycles.
Cicek MN; Kahyaoglu I; Kahyaoglu S
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):539-44. PubMed ID: 25753867
[TBL] [Abstract][Full Text] [Related]
13. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
Smitz J; Andersen AN; Devroey P; Arce JC;
Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
Araujo E; Bernardini L; Frederick JL; Asch RH; Balmaceda JP
J Assist Reprod Genet; 1994 Feb; 11(2):74-8. PubMed ID: 7819706
[TBL] [Abstract][Full Text] [Related]
15. Ovarian androgens but not estrogens correlate with the degree of systemic inflammation observed during controlled ovarian hyperstimulation.
Orvieto R; Fisch N; Yulzari-Roll V; La Marca A
Gynecol Endocrinol; 2005 Sep; 21(3):170-3. PubMed ID: 16335910
[TBL] [Abstract][Full Text] [Related]
16. Should progesterone on the human chorionic gonadotropin day still be measured?
Martinez F; Rodriguez I; Devesa M; Buxaderas R; Gómez MJ; Coroleu B
Fertil Steril; 2016 Jan; 105(1):86-92. PubMed ID: 26453983
[TBL] [Abstract][Full Text] [Related]
17. Endocrine effects of hCG supplementation to recombinant FSH throughout controlled ovarian stimulation for IVF: a dose-response study.
Thuesen LL; Smitz J; Loft A; Nyboe Andersen A
Clin Endocrinol (Oxf); 2013 Nov; 79(5):708-15. PubMed ID: 23448396
[TBL] [Abstract][Full Text] [Related]
18. Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles.
Papaleo E; Corti L; Vanni VS; Pagliardini L; Ottolina J; De Michele F; La Marca A; Viganò P; Candiani M
Arch Gynecol Obstet; 2014 Jul; 290(1):169-76. PubMed ID: 24549270
[TBL] [Abstract][Full Text] [Related]
19. Aspirin inhibits androgen response to chorionic gonadotropin in humans.
Conte D; Romanelli F; Fillo S; Guidetti L; Isidori A; Franceschi F; Latini M; di Luigi L
Am J Physiol; 1999 Dec; 277(6):E1032-7. PubMed ID: 10600792
[TBL] [Abstract][Full Text] [Related]
20. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
